Q4 results ISPC iSpecimen NASDAQ Mar 2026 Mkt Closed: AI agent may shift outlook

ISPC stock reacted to iSpecimen’s Q4 release on 12 Mar 2026 and a new AI product announcement. The company launched an AI-powered Inventory Agent the same day. Shares closed at $0.224, down 6.67% on volume 17,625,940. We review the earnings snapshot, the AI launch, and how these items connect to valuation and near-term price action on NASDAQ in the United States.

ISPC stock: Earnings summary and market move

iSpecimen reported Q4 metrics tied to a small-cap recovery story. The market cap stands at $1,244,204.00 and shares closed at $0.224. EPS remains negative at -7.82, and the trailing PE is -0.03. Trading showed heavy relative volume with 17,625,940 shares changing hands against an average of 1,808,455.00 shares. The price hit a 52-week range low near $0.22 and a high of $3.18 last year.

Product news and strategic impact

iSpecimen launched an AI Inventory Agent built on large language models. Management says the tool automates request review and speeds match rates. This feature aims to reduce manual workload while preserving compliance. Faster matching could shorten sales cycles for biopharma and diagnostics customers and modestly raise marketplace throughput if adoption scales.

ISPC stock: Financials and key metrics

Revenue per share is $0.57 and book value per share is $0.53. Operating cash flow per share is negative at -1.16 and free cash flow per share is -1.16. The current ratio is 0.63, and debt to equity is 0.09. Margins remain pressured with a net profit margin near -3.44% and return on equity at -5.32%.

Technical picture and trading signals

Momentum indicators show a low-risk trend. RSI sits at 38.05 and MACD is neutral. Bollinger Bands range from $0.21 to $0.32. The 50-day average is $0.31 and the 200-day average is $0.79. Short-term setup points to elevated volatility but limited upside without a catalyst.

Meyka AI rates ISPC with a score out of 100

Meyka AI rates ISPC with a score of 66.50 out of 100, Grade B, Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. See our model forecast and cautionary note below. This grade is informational and not investment advice.

Meyka AI forecast and price target

Meyka AI’s forecast model projects a quarterly price of $0.29 versus the current price of $0.224, implying an upside of 29.46%. The model also shows a monthly scenario near $0.04 reflecting downside risk. Forecasts are model-based projections and not guarantees. Review company filings and product adoption before trading. Internal detail and updates at Meyka: ISPC.

Final Thoughts

Key takeaways for ISPC stock after market close on 12 Mar 2026: iSpecimen combined a Q4 update with a product catalyst in the AI Inventory Agent. The news carries operational upside if matching speeds and lead conversion improve. Financials remain weak with negative EPS -7.82 and constrained liquidity metrics. Meyka AI’s forecast model projects a near-term quarterly level of $0.29, implying 29.46% upside versus $0.224 today, but the monthly downside scenario signals high volatility. We expect the stock to trade on adoption milestones, revenue cadence, and any guidance updates. For traders, near-term moves will be catalyst-driven. For longer-term investors, monitor margin improvement, cash runway, and adoption metrics before repositioning.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.